O’Melveny represented TYK Medicines in the transaction. TYK Medicines, Inc. (2410.HK) executed its initial public offering and listing on the Main Board of the Hong Kong...
You must be a Standard 1 Year member to access this content.
Ashurst acted as the U.S. counsel to Shanghai Voicecomm Information Technology, while O’Melveny represented the underwriters on the offering. Shanghai Voicecomm Information Technology Co., Ltd. (2495.HK)...
You must be a Standard 1 Year member to access this content.
O’Melveny represented Ruichang International Holdings Limited on the transaction. Ruichang International Holdings Limited (1334.HK) announced its initial public offering and listing on the Main Board of...
You must be a Standard 1 Year member to access this content.
On the deal, O’Melveny acted for Laopu Gold, Linklaters advised the underwriters. Laopu Gold Co., Ltd. completed the global offering and listing of H shares on...
You must be a Standard 1 Year member to access this content.
O’Melveny represented China International Capital Corporation Hong Kong Securities Limited as the sole sponsor and overall coordinator in the IPO. Qyuns Therapeutics Co., Ltd. (2509.HK) announced...
You must be a Standard 1 Year member to access this content.
O’Melveny represented FOLANGSI CO., LTD in the transaction. FOLANGSI CO., LTD (2499.HK) (“FOLANGSI”) announced its approximately HK$155 million initial public offering and listing of H shares...
You must be a Standard 1 Year member to access this content.
O’Melveny assisted Beijing UBOX Online Technology Corp. on the Hong Kong laws. Sidley acted as international legal counsel for the joint sponsors. Beijing UBOX Online Technology...
You must be a Standard 1 Year member to access this content.
O’Melveny represented the sole sponsor, the coordinators and the underwriters in the transaction. Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) announced its initial public offering and listing...
You must be a Standard 1 Year member to access this content.
O’Melveny advised Acotec Scientific Holdings on the deal. Acotec Scientific Holdings, executed a voluntary partial offering for a majority stake of up to 65% by US-listed Boston...
You must be a Standard 1 Year member to access this content.
O’Melveny advised Beauty Farm. Clifford Chance has advised the joint sponsors. Shearman & Sterling advised Beijing Xinyu Meiye Holdings Limited as a selling shareholder. Beauty Farm...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised the joint sponsors on the deal while O’Melveny represented Sipai Health Technology Co., Ltd, Eight Roads and F-Prime. The joint sponsors Morgan Stanley...
You must be a Standard 1 Year member to access this content.
Cooley advised the joint sponsors and underwriters on the deal while O’Melveny represented Cryofocus Medtech (Shanghai) Co., Ltd. Cryofocus Medtech announced its HK$210 million ($27 million) initial...
You must be a Standard 1 Year member to access this content.
